Matches in Wikidata for { <http://www.wikidata.org/entity/Q96162451> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q96162451 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96162451 description "scientific article published on 06 June 2020" @default.
- Q96162451 description "wetenschappelijk artikel" @default.
- Q96162451 description "наукова стаття, опублікована 6 червня 2020" @default.
- Q96162451 name "Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial" @default.
- Q96162451 name "Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial" @default.
- Q96162451 type Item @default.
- Q96162451 label "Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial" @default.
- Q96162451 label "Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial" @default.
- Q96162451 prefLabel "Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial" @default.
- Q96162451 prefLabel "Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial" @default.
- Q96162451 P1433 Q96162451-085A0BF4-DD4C-455B-A503-3C6CBC36BF38 @default.
- Q96162451 P1476 Q96162451-5769A970-8242-4969-B247-100FDA96C17C @default.
- Q96162451 P2093 Q96162451-47B887E4-3665-4580-BC4D-32AAF7753E25 @default.
- Q96162451 P2093 Q96162451-6D45B3D3-3A62-4AD9-BEDC-A8B174D05823 @default.
- Q96162451 P2093 Q96162451-8D8D0A13-9FCB-4F28-942D-D38FCB21577E @default.
- Q96162451 P2093 Q96162451-AA6C3D57-3759-4A91-81D5-51C634E0C3AF @default.
- Q96162451 P2093 Q96162451-B72ED8C6-7C81-473E-B468-592C77916D59 @default.
- Q96162451 P2093 Q96162451-B8F76E0F-7086-41C5-92F3-087EF6940986 @default.
- Q96162451 P2093 Q96162451-CD05A07B-866B-46A0-92C3-C4E81E49C659 @default.
- Q96162451 P2093 Q96162451-FC134E89-3830-449F-A45C-FCFC7E6904A8 @default.
- Q96162451 P31 Q96162451-75C481BC-BDDF-416A-9C58-3BC3D6766A3E @default.
- Q96162451 P356 Q96162451-E144C0AA-DD79-474C-BC5E-D12103EACC64 @default.
- Q96162451 P50 Q96162451-4C20E57D-66C8-45DB-99C7-CBE29FEFDC2C @default.
- Q96162451 P577 Q96162451-6C1B0BA3-C25E-4CED-8551-FCA2DD64FCB7 @default.
- Q96162451 P698 Q96162451-2276EC4E-8DD8-4978-9C19-989189140BF4 @default.
- Q96162451 P921 Q96162451-AAF7FD07-9BBA-46E5-B585-75507A7AF853 @default.
- Q96162451 P921 Q96162451-C37582AA-466E-4A00-84A1-38CCE1BE891E @default.
- Q96162451 P921 Q96162451-FD6D1FE1-52CE-476E-8DE9-92F30FC17E66 @default.
- Q96162451 P932 Q96162451-68413718-B059-49CF-9FE4-1BCDADEA83C4 @default.
- Q96162451 P356 S11060-020-03551-3 @default.
- Q96162451 P698 32506371 @default.
- Q96162451 P1433 Q15752119 @default.
- Q96162451 P1476 "Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial" @default.
- Q96162451 P2093 "Brett Johnson" @default.
- Q96162451 P2093 "Christopher J Anker" @default.
- Q96162451 P2093 "Dennis C Shrieve" @default.
- Q96162451 P2093 "Howard Colman" @default.
- Q96162451 P2093 "Karen Salzman" @default.
- Q96162451 P2093 "Ken Boucher" @default.
- Q96162451 P2093 "Lindsay M Burt" @default.
- Q96162451 P2093 "Randy Jensen" @default.
- Q96162451 P31 Q13442814 @default.
- Q96162451 P356 "10.1007/S11060-020-03551-3" @default.
- Q96162451 P50 Q91451467 @default.
- Q96162451 P577 "2020-06-06T00:00:00Z" @default.
- Q96162451 P698 "32506371" @default.
- Q96162451 P921 Q413299 @default.
- Q96162451 P921 Q415336 @default.
- Q96162451 P921 Q5452194 @default.
- Q96162451 P932 "7438283" @default.